Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 30, 2025 | December 02, 2025 |
| PROGRESSIVE CORP/OH/PGR · Entity 193 | Director | October 09, 2026 | October 13, 2026 |
| Wheels Up Experience Inc.UP · Entity 6501 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 30, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,438.4534 |
Reported balance
After 2025-11-30 transaction · row 1
1 source rowRow 1 · 2025-11-30 · Tax withholding · Disposed 9,748 · Balance 19,438.4534 F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
PROGRESSIVE CORP/OH/
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Unit (rest. Stock)SEC Table II · derivative / convertible security | Direct | 155,758.3929 |
Reported balance
After 2026-10-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 71.2004 · Balance 155,758.3929 F1: 1 for 1. F2: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3: Expiration Date is the same as the Date Exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: 1 for 1.
F2: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan.
F3: Expiration Date is the same as the Date Exercisable.
Wheels Up Experience Inc.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 24,305 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 24,305 · Balance 24,305 F1: Represents a grant of restricted stock units ("RSUs") under the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as amended by Amendment No. 1 thereto, effective April 15, 2024, Amendment No. 2 thereto, effective March 26, 2025, and Amendment No. 3 thereto, effective March 31, 2026), pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended. The RSUs will be settled in shares of Class A common stock, par value $0.0001 per share, of Wheels Up Experience Inc. (the "Issuer") upon vesting, if at all. The RSUs will vest in four equal quarterly installments on each of (i) September 9, 2026, (ii) December 9, 2026, (iii) March 9, 2027, and (iv) upon the earlier to occur of (a) June 9, 2027 or (b) the date of the next annual meeting of stockholders of the Issuer following June 9, 2027, in each case subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs") under the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as amended by Amendment No. 1 thereto, effective April 15, 2024, Amendment No. 2 thereto, effective March 26, 2025, and Amendment No. 3 thereto, effective March 31, 2026), pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended. The RSUs will be settled in shares of Class A common stock, par value $0.0001 per share, of Wheels Up Experience Inc. (the "Issuer") upon vesting, if at all. The RSUs will vest in four equal quarterly installments on each of (i) September 9, 2026, (ii) December 9, 2026, (iii) March 9, 2027, and (iv) upon the earlier to occur of (a) June 9, 2027 or (b) the date of the next annual meeting of stockholders of the Issuer following June 9, 2027, in each case subject to the Reporting Person's continued service to the Issuer.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 1
1 source rowRow 1 · 2018-11-28 · Disposition to issuer · Disposed 3,000 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-28 · Disposition to issuer · Disposed 18,274.1882 · Balance 0 F2: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 6,000 · Balance 0 F3: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 990 · Balance 0 F4: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.. |
| Deferred Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-11-28 · Disposition to issuer · Disposed 33,730.2412 · Balance 0 F5: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
F3: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount.
F4: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement..
F5: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
TIFFANY & CO
Report date January 07, 2021 · Filed January 11, 2021
Section 16 reporting ended · disclosed 2021-01-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock $.01 ParSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 1
1 source rowRow 1 · 2021-01-07 · Disposition to issuer · Disposed 25,409 · Balance 0 F1: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares). |
| Common Stock $.01 ParSEC Table I · non-derivative | IndirectBy Family Trust | 0 |
Reported balance
After 2021-01-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-01-07 · Disposition to issuer · Disposed 10,000 · Balance 0 F1: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares). |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $93.53 · Expires 2029-06-04 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-01-07 · Disposition to issuer · Disposed 9,489 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $126.44 · Expires 2028-05-24 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-01-07 · Disposition to issuer · Disposed 8,395 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.82 · Expires 2027-05-25 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-01-07 · Disposition to issuer · Disposed 6,749 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares).
F2: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2021 Filed Jul 19, 2021 13:13 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 138.1425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022150 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,989.0685 Underlying: Common · 138.1425 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| May 13, 2021 Filed May 14, 2021 18:12 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016763 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,590 F1 · kind: Restricted stock grant, made pursuant to The Progressive Corporation 2017 Directors Equity Incentive Plan, and which will vest on April 7, 2022. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2021-2022 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2021-2022 term. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,839.326 | $84.27 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-21-016882 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,087.2977 Underlying: Common Stock · 1,839.326 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| April 16, 2021 Filed Dec 30, 2021 20:53 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | OtherCommon | 7.4971 | $100.25 | $751.56 |
DisclosureSEC source: 0001127602-21-032052 · form4.xml · nonDerivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,523.1025 F1 · kind: These shares were acquired upon the reinvestment of dividend equivalents in a broker-sponsored dividend reinvestment plan. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 19:56 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 128.3644 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013997 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,850.926 Underlying: Common · 128.3644 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 18:52 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 4,107 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013536 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,722.5616 Underlying: Common · 4,107 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person, subject to the vesting provisions of the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 18:52 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 4,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013536 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 19, 2021 Filed Dec 30, 2021 20:53 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | OtherCommon | 7.9112 | $94.90 | $750.77 |
DisclosureSEC source: 0001127602-21-032052 · form4.xml · nonDerivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,622.6054 F1 · kind: These shares were acquired upon the reinvestment of dividend equivalents in a broker-sponsored dividend reinvestment plan. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 23:52 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 5,770.566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002046 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,615.5616 Underlying: Common · 5,770.566 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:18 UTC | TIFFANY & CO TIF · Entity 143953 | Disposition to issuerNon-Qualified Stock Option (Right to Buy) · Derivative | 6,749 | Not disclosed Strike: $85.82 | Not disclosed |
DisclosureSEC source: 0000098246-21-000028 · wf-form4_161040347325630.xml · derivative · entry 5 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par · 6,749 shares Expires 2027-05-25 F2 · price: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:18 UTC | TIFFANY & CO TIF · Entity 143953 | Disposition to issuerNon-Qualified Stock Option (Right to Buy) · Derivative | 8,395 | Not disclosed Strike: $126.44 | Not disclosed |
DisclosureSEC source: 0000098246-21-000028 · wf-form4_161040347325630.xml · derivative · entry 4 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par · 8,395 shares Expires 2028-05-24 F2 · price: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:18 UTC | TIFFANY & CO TIF · Entity 143953 | Disposition to issuerNon-Qualified Stock Option (Right to Buy) · Derivative | 9,489 | Not disclosed Strike: $93.53 | Not disclosed |
DisclosureSEC source: 0000098246-21-000028 · wf-form4_161040347325630.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par · 9,489 shares Expires 2029-06-04 F2 · price: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest and less any required withholding taxes, equal to the product of (i) the excess, if any, of (A) the Per Share Merger Consideration over (B) the per-share exercise price for such option, multiplied by (ii) the total number of shares underlying such option. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:18 UTC | TIFFANY & CO TIF · Entity 143953 | Disposition to issuerCommon Stock $.01 Par | 10,000 | $131.50 | $1,315,000.00 |
DisclosureSEC source: 0000098246-21-000028 · wf-form4_161040347325630.xml · nonDerivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares). Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:18 UTC | TIFFANY & CO TIF · Entity 143953 | Disposition to issuerCommon Stock $.01 Par | 25,409 | $131.50 | $3,341,283.50 |
DisclosureSEC source: 0000098246-21-000028 · wf-form4_161040347325630.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of October 28, 2020, by and among Tiffany & Co. (the "Company"), LVMH Moet Hennessy-Louis Vuitton SE ("Parent"), Breakfast Holdings Acquisition Corp. ("Holding") and Breakfast Acquisition Corp. ("Merger Sub") (the "Merger Agreement"), which amended and restated the Agreement and Plan of Merger, dated as of November 24, 2019, by and among the Company, Parent, Holding and Merger Sub, in exchange for $131.50 per share in cash, without interest and less any required withholding taxes (the "Per Share Merger Consideration"). The total number of shares disposed of included 10,355 unvested restricted stock units ("RSUs"), and 5,054 vested RSUs (which includes dividend equivalent units credited in respect of such vested RSUs) as to which the director elected to defer the maturity date (and thereby the delivery of the related shares). Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,336.0965 | $66.35 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-20-029699 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,111.6885 Underlying: Common Stock · 2,336.0965 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| October 16, 2020 Filed Dec 30, 2021 20:53 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | PurchaseCommon | 7.6942 | $97.48 | $750.00 |
DisclosureSEC source: 0001127602-21-032052 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,614.6942 F1 · kind: These shares were acquired upon the reinvestment of dividend equivalents in a broker-sponsored dividend reinvestment plan. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 15:50 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 120.697 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027139 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,844.9956 Underlying: Common · 120.697 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 14:12 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 137.6569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021667 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,724.2986 Underlying: Common · 137.6569 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 18:43 UTC | TIFFANY & CO TIF · Entity 143953 | GrantCommon Stock $.01 Par | 10,355 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-20-000092 · wf-form4_159122419959596.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,340 F1 · shares: Includes 10,355 unvested restricted stock units, which will vest in accordance with their terms on the earlier of the one-year anniversary of the grant date, or the termination of the reporting person's service as a director due to death or disability. F2 · price: Given for no consideration. F3 · balance_after: Includes 15,339 restricted stock units, 2,836 of which are vested; 2,148 of which are scheduled to vest on the earlier of June 4, 2020, or the termination of the reporting person's service as a director due to death or disability; and 10,355 of which are scheduled to vest on the earlier of June 1, 2021, or the termination of the reporting person's service as a director due to death or disability. The reporting person has elected to defer the maturity date of all restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. The 2,836 vested units include 83 accrued dividend equivalent units that were inadvertently omitted from the previously reported total. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,487.5622 | $62.31 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-20-016755 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,649.3333 Underlying: Common Stock · 2,487.5622 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2020 Filed May 12, 2020 18:04 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 4,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016242 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,607 F1 · kind: Restricted stock grant, made pursuant to The Progressive Corporation 2017 Directors Equity Incentive Plan, and which will vest on April 8, 2021. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2020-2021 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2020-2021 term. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 16:54 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 153.7423 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013976 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,586.6417 Underlying: Common · 153.7423 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 16:30 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 4,154 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013662 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,432.8995 Underlying: Common · 4,154 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person, subject to the vesting provisions of the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 16:30 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 4,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013662 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 22:25 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 3,441.3471 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001849 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,278.8995 Underlying: Common · 3,441.3471 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,068.8735 | $74.92 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-19-033566 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,081.1182 Underlying: Common Stock · 2,068.8735 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 19:44 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 145.5862 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030696 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,837.5524 Underlying: Common · 145.5862 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 22:11 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 129.8515 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024796 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,691.9662 Underlying: Common · 129.8515 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 18:39 UTC | TIFFANY & CO TIF · Entity 143953 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 9,489 | $0.00 Strike: $93.53 | $0.00 |
DisclosureSEC source: 0000098246-19-000096 · wf-form4_155986077481388.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,489 Underlying: Common Stock $.01 Par · 9,489 shares Expires 2029-06-04 F4 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2017 Directors Equity Compensation Plan, which complies with Rule 16b-3. The option is exercisable on the first business day following the grant date. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 18:39 UTC | TIFFANY & CO TIF · Entity 143953 | GrantCommon Stock $.01 Par | 2,148 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-19-000096 · wf-form4_155986077481388.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,902 F1 · shares: Includes 2,148 unvested restricted stock units, which will vest in accordance with their terms on the earlier of the one-year anniversary of the grant date, or the termination of the reporting person's service as a director due to death or disability. F2 · price: Given for no consideration. F3 · balance_after: Includes 4,902 restricted stock units, 2,754 of which are vested and 2,148 of which will vest on the earlier of June 4, 2020, or the termination of the reporting person's service as a director due to death or disability. The reporting person has elected to defer the maturity date of all the restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,963.6711 | $52.30 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-19-019151 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,963.6711 Underlying: Common Stock · 2,963.6711 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:06 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 4,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-018460 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,654 F1 · kind: Restricted stock grant, made pursuant to The Progressive Corporation 2017 Directors Equity Incentive Plan, and which will vest on April 10, 2020. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2019-2020 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2019-2020 term. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 20:59 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 150.7874 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015578 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,562.1147 Underlying: Common · 150.7874 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 11, 2019 Filed Apr 15, 2019 20:32 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 4,821 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015462 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,411.3273 Underlying: Common · 4,821 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person, subject to the vesting provisions of the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| April 11, 2019 Filed Apr 15, 2019 20:32 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | Disposition to issuerCommon | 4,821 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015462 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 22:09 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 3,696.405 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005431 · form4.xml · derivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,590.3273 Underlying: Common · 3,696.405 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1. F2 · derivative.exercise_date: These units, which were acquired upon the reinvestment of dividend equivalents, will be paid out in cash at the time elected by the reporting person or at such other time determined in accordance with the plan. F3 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 21:38 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerDeferred Restricted Stock Units · Derivative | 33,730.2412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000171 · edgar.xml · derivative · entry 5 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,730.2412 shares Expires not disclosed F5 · derivative.exercise_price: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F5 · price: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F5 · derivative.exercise_date: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F5 · derivative.expiration_date: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 21:38 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerRestricted Stock Units · Derivative | 990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000171 · edgar.xml · derivative · entry 4 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 990 shares Expires not disclosed F4 · derivative.exercise_price: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.. F4 · price: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.. F4 · derivative.exercise_date: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.. F4 · derivative.expiration_date: Previously reported Restricted Stock Units granted under the Plan on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 21:38 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPhantom Stock Units · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000171 · edgar.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed F3 · derivative.exercise_price: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount. F3 · price: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount. F3 · derivative.exercise_date: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount. F3 · derivative.expiration_date: Previously reported Units granted under the Plan. These Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Unit equal to the Unit Amount. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 21:38 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPhantom Stock Units · Derivative | 18,274.1882 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000171 · edgar.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,274.1882 shares Expires not disclosed F2 · derivative.exercise_price: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F2 · price: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F2 · derivative.exercise_date: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F2 · derivative.expiration_date: Units accrued under the Non-Employee Director Compensation Plan (the "Plan") pursuant to deferral of Director Fees. These Units were canceled pursuant to the terms of the Plan in exchange for an amount (the "Unit Amount") in cash for each Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 21:38 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000171 · edgar.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-034859 · form4.xml · nonDerivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,821 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,308 | $80.27 | $104,993.16 |
DisclosureSEC source: 0001127602-18-034859 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 F1 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the reporting person's 2018-2019 Board service, pursuant to the Registrant's 2017 Incentive Compensation Plan. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 20:12 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantPhantom Stock Units · Derivative | 163.9142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000136 · edgar.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,213.6963 Underlying: Common Stock · 163.9142 shares Expires not disclosed F1 · security: Units accrued under the Aetna Inc. Non-employee Director Compensation Plan (the "Plan) pursuant to the deferral of Director Fees. Subject to the terms of the Plan, units may be settled in Aetna Common Stock, in cash or a combination of both upon the retirement of the Reporting Person. F2 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F2 · price: Units convert to Common Stock on a one-for-one basis. F1 · derivative.exercise_date: Units accrued under the Aetna Inc. Non-employee Director Compensation Plan (the "Plan) pursuant to the deferral of Director Fees. Subject to the terms of the Plan, units may be settled in Aetna Common Stock, in cash or a combination of both upon the retirement of the Reporting Person. F1 · derivative.expiration_date: Units accrued under the Aetna Inc. Non-employee Director Compensation Plan (the "Plan) pursuant to the deferral of Director Fees. Subject to the terms of the Plan, units may be settled in Aetna Common Stock, in cash or a combination of both upon the retirement of the Reporting Person. F3 · balance_after: Includes units accrued under the Plan pursuant to reinvestment of dividend equivalents. Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 20:24 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantPhantom Stock Units · Derivative | 181.1989 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000112 · edgar.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,985.5774 Underlying: Common Stock · 181.1989 shares Expires not disclosed F1 · security: Units accrued under the Aetna Inc. Non-employee Director Compensation Plan (the "Plan) pursuant to tthe deferral of Director Fees. Subject to the terms of the Plan, units may be settled in Aetna Common Stock, in cash or a combination of both upon the retirement of the Reporting Person. F2 · security: Units convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F2 · price: Units convert to Common Stock on a one-for-one basis. F1 · derivative.exercise_date: Units accrued under the Aetna Inc. Non-employee Director Compensation Plan (the "Plan) pursuant to tthe deferral of Director Fees. Subject to the terms of the Plan, units may be settled in Aetna Common Stock, in cash or a combination of both upon the retirement of the Reporting Person. F1 · derivative.expiration_date: Units accrued under the Aetna Inc. Non-employee Director Compensation Plan (the "Plan) pursuant to tthe deferral of Director Fees. Subject to the terms of the Plan, units may be settled in Aetna Common Stock, in cash or a combination of both upon the retirement of the Reporting Person. F3 · balance_after: Includes units accrued under the Plan pursuant to reinvestment of dividend equivalents. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:49 UTC | TIFFANY & CO TIF · Entity 143953 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 8,395 | $0.00 Strike: $126.44 | $0.00 |
DisclosureSEC source: 0000098246-18-000235 · wf-form4_152764492055403.xml · derivative · entry 3 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,395 Underlying: Common Stock $.01 Par · 8,395 shares Expires 2028-05-24 F4 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2017 Directors Equity Compensation Plan, which complies with Rule 16b-3. The option is exercisable on the first business day following the grant date. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:49 UTC | TIFFANY & CO TIF · Entity 143953 | GrantCommon Stock $.01 Par | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-18-000235 · wf-form4_152764492055403.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,754 F1 · shares: Includes 1,598 unvested restricted stock units, which will vest in accordance with their terms on the earlier of the one-year anniversary of the grant date, or the termination of the reporting person's service as a director due to death or disability. F2 · price: Given for no consideration. F3 · balance_after: Includes 2,754 restricted stock units, 1,156 of which are vested and 1,598 of which will vest on the earlier of May 24, 2019, or the termination of the reporting person's service as a director due to death or disability. The reporting person has elected to defer the maturity date of all the restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. Read SEC document |
| May 23, 2018 Filed May 25, 2018 18:26 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantCommon | 4,821 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018946 · form4.xml · nonDerivative · entry 1 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,321 F1 · kind: Restricted stock grant, made pursuant to The Progressive Corporation 2017 Directors Equity Incentive Plan, and which will vest on April 11, 2019. The Progressive Corporation allowed each director to indicate his or her preference to receive compensation for the 2018-2019 term in the form of 100% restricted stock or 60% restricted stock and 40% cash. The reporting person indicated a preference to receive compensation in the form of 100% restricted stock. After considering such preference, the Compensation Committee granted a restricted stock award representing 100% of the reporting person's compensation for the 2018-2019 term. Read SEC document |
| May 18, 2018 Filed May 22, 2018 20:05 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000094 · edgar.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 Underlying: Common Stock · 990 shares Expires not disclosed F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F1 · price: Units convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be issued in Common Stock. F2 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be issued in Common Stock. Read SEC document |
| April 12, 2018 Filed Apr 13, 2018 19:08 UTC | PROGRESSIVE CORP/OH/ PGR · Entity 193 | GrantPhantom Stock Unit (rest. Stock) · Derivative | 6,879 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014519 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,893.9221 Underlying: Common · 6,879 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1. F1 · price: The reporting person elected to defer receipt of previously granted restricted common shares upon vesting thereof. This Form 4 reports the disposition of such restricted shares in exchange for an equal number of units under the applicable deferred compensation plan. F3 · derivative.exercise_date: These units will be paid out in an equal number of Common Shares at the time elected by the reporting person, subject to the vesting provisions of the plan. F4 · derivative.expiration_date: Expiration Date is the same as the Date Exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.